BBIO | Bridgebio Pharma Inc 65.43 -0.62 (-0.96%)
Category: Consumer goods
Quick infos Trade prices Volume: Market Cap: Prev closed: Open: High: Low: 52 week low: 52 week high: Dividends:
Earnings History Date EPS / Forecast Revenue / Forecast May 19, 2021 March 8, 2021 November 5, 2020 -0.98 / -0.89788.13M / 10.75MAugust 11, 2020 -1.03 / -0.77- / -May 13, 2020 -0.78 / -0.67- / -view more
Historical Data Date Price Open High Low Vol Change ER Jan 8, 2021 65.51 65.14 66.63
62.94
600.83K 1.08% Jan 7, 2021 64.81 64.87 65.80
64.31
786.32K 0.90% Jan 6, 2021 64.23 64.67 65.94
63.39
565.78K -1.26% Jan 5, 2021 65.05 63.22 65.88
62.74
723.45K 2.22% Jan 4, 2021 63.64 71.39 71.39
63.09
992.75K -10.5% Dec 31, 2020 71.11 69.34 71.41
68.56
436.38K 1.48% Dec 30, 2020 70.07 68.38 70.85
68.38
415.68K 3.62% Dec 29, 2020 67.62 69.39 69.76
66.20
664.35K -2.68% Dec 28, 2020 69.48 70.44 70.71
68.58
462.97K -0.03% Dec 24, 2020 69.50 69.58 70.56
68.51
302.77K 0.59% view more
News
BridgeBio Pharma and Affiliate Origin Biosciences Announces FDA Acceptance of its New Drug Application for Fosdenopterin for the Treatment of MoCD Type A finance.yahoo.com Oct 5, 2020 7:30 am BridgeBio to buy Eidos Therapeutics in a cash and stock deal valuing Eidos at $2.8 billion marketwatch.com Oct 5, 2020 7:21 am
Analysts Are Betting On BridgeBio Pharma, Inc. (NASDAQ:BBIO) With A Big Upgrade This Week finance.yahoo.com Oct 5, 2020 6:03 am
2 Under-the-Radar Biotech Stocks You'll Wish You Didn't Ignore fool.com Oct 3, 2020 6:07 am
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) finance.yahoo.com Sep 3, 2020 5:30 pm
BridgeBio and Eidos Present Data from Phase 2 Open Label Extension Suggesting Long-term Tolerability of AG10 and Stabilization of Transthyretin Amyloid Cardiomyopathy Disease Measures finance.yahoo.com Aug 12, 2020 5:30 pm Adaptive Biotech and BridgeBio shares rocket higher on their first day of trade marketwatch.com Aug 12, 2020 11:25 am BridgeBio prices IPO at $17 a share, above its $14 to $16 price range marketwatch.com Aug 12, 2020 9:24 am
BridgeBio Pharma, Inc. Enters Into Collaboration Agreement With Johns Hopkins University to Accelerate Development of New Medicines in Genetically Driven Diseases finance.yahoo.com Aug 12, 2020 7:30 am
BridgeBio Pharma, Inc. Announces Proposed Offering of $350 Million Convertible Senior Notes finance.yahoo.com Aug 12, 2020 7:00 am BridgeBio Pharma inks licensing pact for its oncology candidates with LianBio in China seekingalpha.com Aug 11, 2020 10:26 pm BridgeBio Pharma EPS misses by $0.23 seekingalpha.com Aug 11, 2020 7:47 pm BioMarin files EU marketing application for vosoritide for type of dwarfism seekingalpha.com Jul 24, 2020 5:07 am
BridgeBio Pharma, Inc. Reports Second Quarter 2020 Financial Results and Business Update finance.yahoo.com Aug 11, 2020 7:40 am
Ivy Brain Tumor Center and BridgeBio Pharmas QED Therapeutics Announce Dosing of First Patient in Investigator-Initiated Phase 0/2 Clinical Trial of Infigratinib in Recurrent Glioblastoma finance.yahoo.com Jul 28, 2020 7:30 am Mid-stage study underway on BridgeBio's infigratinib for bone growth disorder seekingalpha.com Jul 15, 2020 8:10 pm
BridgeBio Pharmas Phoenix Tissue Repair to Highlight Interim Phase 1/2 Study Data in a Presentation at the Society for Pediatric Dermatologys 45th Annual Meeting finance.yahoo.com Jul 10, 2020 7:30 am Mixed shelf roundup - healthcare seekingalpha.com Jul 10, 2020 12:34 am
Hedge Funds Are Nibbling On BridgeBio Pharma, Inc. (BBIO) finance.yahoo.com Jul 5, 2020 3:43 pm
BridgeBio Pharma, Inc. Reports First Quarter 2020 Financial Results and Business Update finance.yahoo.com Jul 2, 2020 4:01 pm Talk about Bridgebio Pharma Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon Very few careers can offer you the freedom, flexibility, and income that day trading does. As a day trader, you can live and work anywhere in the world. You can decide when to work and when not to work. You only answer to yourself. That is the life of the successful day trader. Many people aspire to it, but very few succeed.
A Beginner's Guide to Trading Tools and Tactics, Money Management, Discipline and Trading Psychology
